Skip to main content
RNAC $9.60 -3.71%
RNAC logo
RNAC · Cartesian Therapeutics, Inc.
Track RNAC — free
$9.60 -0.37 (-3.71%) At close · Aug 28
Market Cap
$290.60M
Shares
30.26M
All earnings calls

Earnings call · FY2022 Q2

Cartesian Therapeutics, Inc. (RNAC) Q2 2022 Earnings Call

Concluded Aug 4, 2022
Aug 4, 2022 0 turns
Period
FY2022 Q2
Runtime
Sources
2 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue $39.27M +99.7% YoY
Diluted EPS $1.80
Net income $8.60M +88.4% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

Full-screen source Call document